- Home
- FTFT vs LGVN Comparison
FTFT vs LGVN Comparison
Compare FTFT & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- LGVN
- Stock Information
- Founded
- FTFT N/A
- LGVN 2014
- Country
- FTFT United States
- LGVN United States
- Employees
- FTFT N/A
- LGVN N/A
- Industry
- FTFT Business Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- FTFT Consumer Discretionary
- LGVN Health Care
- Exchange
- FTFT Nasdaq
- LGVN Nasdaq
- Market Cap
- FTFT 11.0M
- LGVN 11.5M
- IPO Year
- FTFT N/A
- LGVN 2021
- Fundamental
- Price
- FTFT $2.20
- LGVN $0.80
- Analyst Decision
- FTFT
- LGVN Strong Buy
- Analyst Count
- FTFT 0
- LGVN 3
- Target Price
- FTFT N/A
- LGVN $6.33
- AVG Volume (30 Days)
- FTFT 139.5K
- LGVN 1.9M
- Earning Date
- FTFT 08-19-2025
- LGVN 08-13-2025
- Dividend Yield
- FTFT N/A
- LGVN N/A
- EPS Growth
- FTFT N/A
- LGVN N/A
- EPS
- FTFT N/A
- LGVN N/A
- Revenue
- FTFT $2,368,206.00
- LGVN $2,073,000.00
- Revenue This Year
- FTFT N/A
- LGVN N/A
- Revenue Next Year
- FTFT N/A
- LGVN $51.48
- P/E Ratio
- FTFT N/A
- LGVN N/A
- Revenue Growth
- FTFT N/A
- LGVN 68.67
- 52 Week Low
- FTFT $1.01
- LGVN $0.63
- 52 Week High
- FTFT $5.70
- LGVN $2.86
- Technical
- Relative Strength Index (RSI)
- FTFT 56.83
- LGVN 33.36
- Support Level
- FTFT $1.75
- LGVN $0.73
- Resistance Level
- FTFT $1.94
- LGVN $0.87
- Average True Range (ATR)
- FTFT 0.20
- LGVN 0.13
- MACD
- FTFT -0.00
- LGVN -0.03
- Stochastic Oscillator
- FTFT 83.95
- LGVN 17.43
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.